Newsbenzinga
Zoetis' Acquisition of Neogen Genomics Business Faces Regulatory Scrutiny in Australia
· Published
Article summary
The Australian agency is conducting a Phase 2 assessment of Zoetis' $160 million acquisition of Neogen's genomics unit due to competition concerns.
An excerpt from the original article.
Comments —
Loading comments…